PROTAGENIC THERAPEUTICS INC (PTIX)

Protagenic Therapeutics says board approved 1-for-4 reverse stock split (NASDAQ:PTIX)

Protagenic Therapeutics (PTIX) on Wednesday announced it has approved a 1-for-4 reverse stock split of the company's issued and outstanding common stock.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning!

Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th

NEW YORK, NY / ACCESSWIRE / April 26, 2022 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX) a biopharmaceutical company focused on developing drug product candidates to treat stress-related neurologic disorders, today announced will be presenting at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference tomorrow, April 27, 2022. The presentation details are as follows: Date: Wednesday, April 27, 2022 Time: 10:30 AM ET Link:

Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to...

Maxim Group Thinks Protagenic Therapeutics’ Stock is Going to Recover

Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET

Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update

Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial

50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th - 15th, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period as well as 1x1 meetings with qualified investors throughout the event. John Hope Bryant, guest host on CNBC and CEO of Operation HOPE will deliver the keynote to kick off the

Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 AM ET

50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual presentations as well as private meetings with qualified investors throughout the three-day event. Company Presentations will begin July 13 at 10 am eastern time and go through July 15th. The event will also include a keynote speaker (to be